JP2017529377A5 - - Google Patents

Download PDF

Info

Publication number
JP2017529377A5
JP2017529377A5 JP2017516659A JP2017516659A JP2017529377A5 JP 2017529377 A5 JP2017529377 A5 JP 2017529377A5 JP 2017516659 A JP2017516659 A JP 2017516659A JP 2017516659 A JP2017516659 A JP 2017516659A JP 2017529377 A5 JP2017529377 A5 JP 2017529377A5
Authority
JP
Japan
Prior art keywords
foam
forming
body cavity
pharmaceutical composition
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017516659A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017529377A (ja
JP6659674B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2015/051011 external-priority patent/WO2016048230A1/en
Publication of JP2017529377A publication Critical patent/JP2017529377A/ja
Publication of JP2017529377A5 publication Critical patent/JP2017529377A5/ja
Application granted granted Critical
Publication of JP6659674B2 publication Critical patent/JP6659674B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017516659A 2014-09-25 2015-09-25 泡沫形成組成物、及び活性剤を体腔に送達するための方法 Expired - Fee Related JP6659674B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462055001P 2014-09-25 2014-09-25
US62/055,001 2014-09-25
PCT/SE2015/051011 WO2016048230A1 (en) 2014-09-25 2015-09-25 Foam-forming compositions and methods for delivering an active agent to a body cavity

Publications (3)

Publication Number Publication Date
JP2017529377A JP2017529377A (ja) 2017-10-05
JP2017529377A5 true JP2017529377A5 (OSRAM) 2018-10-11
JP6659674B2 JP6659674B2 (ja) 2020-03-04

Family

ID=55581573

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017516659A Expired - Fee Related JP6659674B2 (ja) 2014-09-25 2015-09-25 泡沫形成組成物、及び活性剤を体腔に送達するための方法

Country Status (16)

Country Link
US (1) US9895311B2 (OSRAM)
EP (2) EP3197431B1 (OSRAM)
JP (1) JP6659674B2 (OSRAM)
KR (1) KR102569954B1 (OSRAM)
CN (1) CN106687109B (OSRAM)
AU (1) AU2015322112B2 (OSRAM)
BR (1) BR112017006154B1 (OSRAM)
CA (1) CA2959717C (OSRAM)
DK (1) DK3197431T3 (OSRAM)
ES (1) ES2946510T3 (OSRAM)
FI (1) FI3197431T3 (OSRAM)
HU (1) HUE062224T2 (OSRAM)
PL (1) PL3197431T3 (OSRAM)
PT (1) PT3197431T (OSRAM)
RU (1) RU2710019C2 (OSRAM)
WO (1) WO2016048230A1 (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9895311B2 (en) * 2014-09-25 2018-02-20 Pharmiva Ab Foam-forming compositions and methods for delivering an active to a body cavity
WO2018013474A1 (en) * 2016-07-11 2018-01-18 Hennepin Life Sciences, Llc Compositions for sexually transmitted diseases
FI3628002T3 (fi) * 2017-05-23 2023-05-15 Pharmiva Ab Vaahtoa muodostavat koostumukset aktiivisen aineen kuljettamiseksi kehon onteloon
BR112023015156A2 (pt) 2021-01-27 2024-01-16 Pharmiva Ab Composição para uso na degradação ou prevenção da formação de biofilme
JP2024522372A (ja) * 2021-06-11 2024-06-18 アンク、ライフ、サイエンシズ、リミテッド 有効薬剤の組合せの局所送達のための安定性が向上した脂質結晶性組成物

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684479A (en) 1985-08-14 1987-08-04 Arrigo Joseph S D Surfactant mixtures, stable gas-in-liquid emulsions, and methods for the production of such emulsions from said mixtures
SE454397B (sv) * 1985-12-20 1988-05-02 Biogram Ab Stabiliserad vattenbaserad antimikrobiell veteperoxidkomposition, forfarande for framstellning derav samt anvendning derav som antimikrobiell spendoppningskomposition for mjolkproducerande djur
JPH06279228A (ja) 1993-03-30 1994-10-04 Kao Corp 発泡性組成物
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
JPH07197083A (ja) 1993-12-28 1995-08-01 Kao Corp 洗浄剤組成物
US5741525A (en) 1995-10-24 1998-04-21 Marshall University Research Corporation Vaginal pharmaceutical hydrogen peroxide composition
US5778886A (en) * 1996-02-27 1998-07-14 Shihata; Alfred Vaginal compositions combining a spermicidal agent and a peroxygen compound
US6156294A (en) 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US20020031556A1 (en) * 2000-07-21 2002-03-14 Lindahl Ake R. Stabilized hydrogen peroxide composition and method of making a stabilized hydrogen peroxide composition
US7709026B2 (en) 2001-10-29 2010-05-04 Columbia Laboratories, Inc. Low concentration of peroxide for treating or preventing vaginal infections
WO2005018530A2 (en) * 2003-08-25 2005-03-03 Foamix Ltd. Penetrating pharmaceutical foam
US20070292355A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
ES2637956T3 (es) 2003-01-24 2017-10-18 Stiefel Research Australia Pty Ltd Espuma farmacéutica
US8193244B1 (en) 2008-05-29 2012-06-05 Nevada Naturals, Inc. Antimicrobial agents
US20040197270A1 (en) * 2003-04-01 2004-10-07 Mundschenk David D. Topical formulations and delivery systems
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
EP1768648A1 (en) 2004-04-28 2007-04-04 Foamix Ltd. Body cavity foams
CN101137359B (zh) 2005-03-10 2011-01-12 3M创新有限公司 治疗耳感染的方法
US20070299043A1 (en) * 2005-10-03 2007-12-27 Hunter William L Anti-scarring drug combinations and use thereof
WO2007079069A1 (en) * 2005-12-29 2007-07-12 3M Innovative Properties Company Foamable dental compositions and methods
WO2008075207A2 (en) 2006-04-04 2008-06-26 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
WO2008110872A2 (en) * 2006-06-23 2008-09-18 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
ES2482190T3 (es) * 2007-03-30 2014-08-01 Laccure Ab Uso de oligómeros de ácido láctico en el tratamiento de infecciones ginecológicas
RS52337B (sr) * 2007-06-19 2012-12-31 Neubourg Skin Care Gmbh & Co. Kg Dms kreme na bazi pene
US20090239775A1 (en) * 2008-03-19 2009-09-24 Collins Gary L Ophthalmic solutions displaying improved efficacy
US8871184B2 (en) 2009-10-02 2014-10-28 Foamix Ltd. Topical tetracycline compositions
US8414868B2 (en) * 2010-02-04 2013-04-09 Ultradent Products, Inc. In situ foamable dental bleaching compositions and methods, systems and kits for bleaching teeth using such compositions
CN105338963A (zh) * 2013-04-26 2016-02-17 贝欧格兰公司 用于减少痂形成并促进愈合的组合物
US9895311B2 (en) * 2014-09-25 2018-02-20 Pharmiva Ab Foam-forming compositions and methods for delivering an active to a body cavity

Similar Documents

Publication Publication Date Title
JP2017529377A5 (OSRAM)
JP2023017050A5 (OSRAM)
US20240173359A1 (en) Ammonia oxidizing microorganisms for use and delivery to the urogenital system
HRP20110429T1 (hr) Pripravak koji se može pjeniti uglavnom bez farmaceutskih aktivnih sastojaka za liječenje kože kod ljudi
RU2017112055A (ru) Пенообразующие композиции и способы доставки активного агента в полость тела
JP2014500257A5 (OSRAM)
CN101642467B (zh) 长效消毒膏
FI3628002T3 (fi) Vaahtoa muodostavat koostumukset aktiivisen aineen kuljettamiseksi kehon onteloon
JP2013519695A5 (OSRAM)
RU2018125252A (ru) Синергическая комбинация пирролидонкарбоновой кислоты и/или ее солей и гиалуроновой кислоты и/или ее солей для применения в лечении и/или профилактике сухости и раздражения слизистых оболочек, и связанные фармацевтические композиции
JP6857644B2 (ja) 直腸の炎症性変化の治療用医薬製剤
OA20623A (en) Foam-forming compositions for delivering an active to a body cavity.
OA18854A (en) Foam-Forming Compositions and Methods for Delivering an Active Agent to a Body Cavity
HK40017987B (en) Foam-forming compositions for delivering an active to a body cavity
HK40017987A (en) Foam-forming compositions for delivering an active to a body cavity
HK1242202B (en) Foam-forming compositions and methods for delivering an active agent to a body cavity